Last reviewed · How we verify

NCT05023239

Ultrasound-Guided Suprazygomatic Maxillary Nerve Block as A Part of Multimodal Analgesic Regimens

Status unknown EARLY_PHASE1 Last updated 26 August 2021
What this trial tests

EARLY_PHASE1 trial testing UG-SZM Group in Suprazygomatic Maxillary Nerve Block in 52 participants. Status unknown.

Timeline
1 October 2021
Primary endpoint
1 October 2022
1 December 2022

Quick facts

Lead sponsorCairo University
PhaseEARLY_PHASE1
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposeprevention
Enrollment52
Start date1 October 2021
Primary completion1 October 2022
Estimated completion1 December 2022

Drugs / interventions tested

Conditions studied

Sponsor

Cairo University

Who can join

Adults 4 to 12, any sex, with Suprazygomatic Maxillary Nerve Block. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Inadequate peri-operative analgesia may contribute to an increased risk of bleeding, suture dehiscence and unacceptable surgical outcomes. Moreover, these patients are at high risk of postoperative airway obstruction and respiratory failure. Opioids may contribute to these complications. Appropriate use of regional anaesthesia may mitigate or eliminate many of these concerns. The maxillary nerve is responsible for the sensory innervation of the midface, including the hard and soft palates, upper jaw, upper dental arch and upper lip.Recently, the successful use of maxillary nerve block by the suprazygomatic approach has been reported in children undergoing cleft palate surgery. However, the use of this block has not been described in large series of patients, and the effectiveness of the suprazygomatic approach has not been evaluated in patients undergoing tonsillectomy .

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Cairo University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05023239.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing